Showing 31 - 40 of 24,839
This paper examines FRAND issues in India. From an institutional perspective, India's FRAND cases do not effectively establish the appropriate role for antitrust in FRAND. On the one hand, there is the potential for hold-up and anti-competitive conduct in the FRAND setting. Such situations would...
Persistent link: https://www.econbiz.de/10013000998
Governments often subsidize poorer groups in society to ensure their access to new drugs. We analyse the optimal income‐based price subsidies in a strategic environment. We show that universal access is less likely to arise when price arbitrage prevents international price discrimination. When...
Persistent link: https://www.econbiz.de/10012835185
In the last several years, India has raised several novel and controversial concerns regarding standard-essential patents (SEPs). For example, in 2013 and 2014, the Competition Commission of India (CCI) issued investigation orders against Ericsson, alleging that the company violated its...
Persistent link: https://www.econbiz.de/10012968512
Persistent link: https://www.econbiz.de/10012659758
We study how the assignment of property rights between employees and their employers influences disclosures that reveal the productivity and ability of individual employees. To do so, we examine the effect of a court ruling that significantly shifted the assignment of intellectual property...
Persistent link: https://www.econbiz.de/10013242694
are continually seeking to strengthen their legal entitlements by arguing that stronger copyright incentives fuel future …
Persistent link: https://www.econbiz.de/10012752451
Persistent link: https://www.econbiz.de/10010187947
Persistent link: https://www.econbiz.de/10012418734
Persistent link: https://www.econbiz.de/10012231703
influence the incentives for challenging patents, the question arises whether the antitrust assessment of patent settlements … should also consider their impact on the incentives to challenge potentially invalid patents. Patent settlements in the … between limiting the delay of generic entry through patent settlements and giving generic firms more incentives for …
Persistent link: https://www.econbiz.de/10011579217